东阳光药业集团
成立年份：2002
总资产（USD）：不愿意公开
员工总人数：500以上
主要竞争优势：国际认证/标准，经验丰富的研发人员，生产能力，接受小额订单，良好的信誉
业务类型：制造商，出口商
年销售额（USD）：100,000,000至249,999,999
主要销售市场：北美洲，西欧，亚洲
主要产品类别：原料药，中间体
所有产品： HEC’s Drug Substances (APIs) Catalog API Name Commercial availability Standards DMF/CEP/FDA Atorvastatin calcium Now Ph.Eur and USP CEP 2012-382 Levofloxacin Now USP and CP DMF No.: 26295 Esomeprazole sodium Now In-house standard DMF available Esomeprazole magnesium Now Ph.Eur and USP DMF available Olanzapine Now Ph.Eur, USP and National Standard CEP 2012-406 DMF 26763 Felodipine Now Ph.Eur, USP and CP CEP 2013-023 DMF 26811 Entacapone Now Ph.Eur and USP DMF available in 2013 Prasugrel hydrochloride Now In-house standard DMF 26769 Bambuterol Now Ph.Eur and CP NA Azilsartan Now In-house standard DMF available in 2013 Simvastatin Now Ph.Eur, USP and CP DMF 26843 Irbesartan Now Ph.Eur, USP and CP CEP 2012-027 DMF 26802 Moxifloxacin Now Ph.Eur and USP DMF available in 2013 Metoprolol succinate Now Ph.Eur and USP DMF available in 2013 Fingolimod Now In-house standard DMF available in 2013 Rosuvastatin calcium Now In-house standard DMF available in 2013 Pitavastatin calcium Now In-house standard DMF available in 2013 Clopidogrel Now Ph.Eur and USP DMF available in 2013 Azilsartan medoxomil Now In-house standard DMF available in 2013 Erlotinib 2013 In-house standard DMF available in 2013 Olmesartan medoxomil 2013 Ph.Eur and USP DMF available in 2013 Candesartan cilexetil 2013 Ph.Eur, USP and CP DMF available in 2013 Entecavir 2013 In-house standard DMF available in 2013 Escitalopram 2013 USP DMF available in 2013 Pregabalin 2013 In-house standard Pending Imatinib 2013 In-house standard Pending Tigecycline 2013 In-house standard Pending Aripiprazole 2013 National standard Pending Telaprevir 2013 In-house standard Pending Ticagrelor 2013 In-house standard Pending Apixaban 2013 In-house standard Pending Rivaroxaban 2013 In-house standard Pending Duloxedine 2013 Ph.Eur Pending Dexlansoprazole 2013 In-house sandard Pending Pantoprazole 2013 Ph.Eur, USP and CP Pending Quetiapine 2013 Ph.Eur, USP and CP Pending Sitagliptin 2013 In-house standard Pending
联系人：周雪娇
电话：86-769-85315888-2603-2109
传真：86-769-85370255
公司地址：湖北省宜都市滨江路38号
HEC Pharm Group is an emerging pharmaceutical company specialized in development, production and marketing of quality and affordable generics, APIs and intermediates for worldwide markets. HEC also provides services for contract R&D and manufacturing.
All manufacture facilities of HEC have been GMP certified by both U.S FDA and European authorities. HEC can provide the value added formulations based on its strong R&D capability. HEC has Zidovudine tablets approved by U.S FDA and Azithromycin tablets approved by German BfArM and WHO.
The company also offers qualified APIs with DMF and CEP, such as Telaprevir, Atorvastatin, Ticagrelor, Clopidogrel, Azilsartan, etc.
